PNC Financial Services Group’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
Other funds holding AXDX
GAM
BC
OIM
CC
CI
PNC Financial Services Group's AXDX Position: Q3 2023 in Review
PNC Financial Services Group sold out of Accelerate Diagnostics (AXDX) in Q3 2023, closing a stake of 20 shares — an estimated $162 sold.
PNC Financial Services Group first reported a position in AXDX in Q3 2016 and held it in 17 quarters. The position peaked at $88K in Q2 2017. 38 funds tracked by Wall St. Rank hold AXDX as of Q3 2023.
- PNC Financial Services Group reported no remaining Accelerate Diagnostics position as of Q3 2023 after selling out during the quarter.
- PNC Financial Services Group sold 20 Accelerate Diagnostics shares in Q3 2023, an estimated $162.
- PNC Financial Services Group first reported a position in Accelerate Diagnostics in Q3 2016 and held it in 17 quarters.
- PNC Financial Services Group's Accelerate Diagnostics position peaked at $88K in Q2 2017.
- 38 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q3 2023.
Based on PNC Financial Services Group's 13F filing for Q3 2023, filed 13 Nov 2023.